Acadia Pharmaceuticals buy UBS Group AG
Start price
09.09.25
/
50%
€20.96
Target price
09.09.26
€33.13
Performance (%)
24.33%
Price
18.08.26
€26.06
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG currently has a performance of 24.33%. This prediction currently runs until 09.09.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 2.316% | 2.316% |
| iShares Core DAX® | -0.874% | 5.325% |
| iShares Nasdaq 100 | -0.381% | 1.979% |
| iShares Nikkei 225® | -1.676% | 1.952% |
| iShares S&P 500 | -0.655% | 2.069% |
Comments by UBS_Group_AG for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target raised by analysts at UBS Group AG from $36.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by UBS_Group_AG for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.07
06.01.26
06.01.26
€34.12
06.01.27
06.01.27
12.96%
18.08.26
18.08.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.27
04.12.25
04.12.25
-
04.12.26
04.12.26
11.99%
18.08.26
18.08.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.15
08.08.25
08.08.25
€30.87
08.08.26
08.08.26
18.82%
09.08.26
09.08.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.56
08.08.24
08.08.24
€21.10
08.08.25
08.08.25
43.94%
09.08.25
09.08.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.80
17.10.23
17.10.23
€31.28
17.10.24
17.10.24
-36.33%
18.10.24
18.10.24